RESUMO
Recognizing reality, Uwe Schoenbeck, PhD, senior vice president and chief scientific officer for Emerging Science & Innovation (ES&I) at Pfizer, has synthesized and made functional core lessons from two of the past decade's best business books: According to Schoenbeck, ESLs are highly experienced in the relevant disease area and embedded within the respective therapeutic areas, resulting in high strategic alignment of the opportunity being sourced and avoiding opportunities that are not a strategic fit (1). The ES&I team, in conjunction with colleagues working in Business Development, has stood out for bringing genuinely creative partnership ideas and innovations into an already creative and crowded environment. [...]a collaboration with Codex DNA will potentially streamline the mRNA production process by facilitating synthetic DNA assembly, another notable fruit of the team's labour to bring forth a competitive pipeline in gene therapy.
RESUMO
Platform businesses allow for collaboration with nontraditional partners and bring together different categories of customers, in the financial context savers and investors or lenders and borrowers, creating large, scalable networks of users. Their entry into finance promises potential benefits to consumers in the form of new products, lower prices, wider choice, and enhanced consumer experience. At the same time, their new business models and technologies potentially threaten the dominant position of traditional financial services providers and create challenges for regulators. Platform businesses can use their preferential access to customer data to skim off high-quality loans, leaving only low-quality customers for other lenders. Their ability to offer complementary nonfinancial services that cannot be supplied by FinTech start-ups and banks can make it difficult or unattractive for customers to switch to alternative providers. This danger is especially acute when BigTech firms have monopoly power in other markets that complement financial services.
RESUMO
Many projects in Indonesia have implemented new strategies in response to the COVID-19 outbreak. Many projects suffered unexpected losses during the COVID-19 pandemic, and conditions were unpredictable. This situation must be considered by all stakeholders participating in a project. Another problem in the implementation of construction is the fragmentation between project participants. Therefore, a strategy is needed in each phase of the project life cycle. In the absence of proper planning, the contractor is the party responsible for bearing the risk associated with this occurrence. Improved project performance is a shared responsibility among owners, contractors, designers, and subcontractors, all of whom need to tap into their own sources of creativity and innovation. The potential of partnering as a tool for achieving lean construction performance, it is still in its infancy as a means of enhancing project outcomes. In this study, we used qualitative methods and in-depth interviews enhanced by focus group discussions of 14 experts (owners, designers, contractors, and academics) using the Delphi method. The results illustrate the maturity of partnering in integrated project delivery (IPD);therefore, its guiding philosophy can be developed and implemented to improve the outcomes of construction projects in terms of cost, quality, schedule, health and safety, and environmental performance. The most important part of this research is related to the implementation of the 17th goal of the Sustainable Development Goals (SDGs), i.e., partnerships to achieve the goals. This research contributes to a deepening of partnering practices that can drive performance in project implementation.
RESUMO
PURPOSE: The purpose of this paper is to argue for an improved conceptualisation of health service research, using Stengers' (2018) metaphor of "slow science" as a critical yardstick. DESIGN/METHODOLOGY/APPROACH: The paper is structured in three parts. It first reviews the field of health services research and the approaches that dominate it. It then considers the healthcare research approaches whose principles and methodologies are more aligned with "slow science" before presenting a description of a "slow science" project in which the authors are currently engaged. FINDINGS: Current approaches to health service research struggle to offer adequate resources for resolving frontline complexity, principally because they set more store by knowledge generalisation, disciplinary continuity and integrity and the consolidation of expertise, than by engaging with frontline complexity on its terms, negotiating issues with frontline staff and patients on their terms and framing findings and solutions in ways that key in to the in situ dynamics and complexities that define health service delivery. ORIGINALITY/VALUE: There is a need to engage in a paradigm shift that engages health services as co-researchers, prioritising practical change and local involvement over knowledge production. Economics is a research field where the products are of natural appeal to powerful health service managers. A "slow science" approach adopted by the embedded Economist Program with its emphasis on pre-implementation, knowledge mobilisation and parallel site capacity development sets out how research can be flexibly produced to improve health services.